Advanced search for available technology

  Username(email)             Password
  (Same as The Knowledge Vine if you are a Vine user)This service is provided free by UMIP^®

          

Latest IP offers

A new generation of small peptides (6-12mers) with potent in vitro and in vivo activity against influenza A viruses     |       Fuel cell technology that converts Urine / Urea / Ammonia to energy and clean water - low cost viable alternative to H2     |       A method of assessing efficiency of internal combustion engines      |       Software for viewwing, manipulating and interpreting LiDAR (ground penetrating radar) data      |       A s/w programmable CMOS chip in which an image processor is integrated within each pixel of the image sensor     |

Latest Tech Requests

Reduction of sodium andamp; saturated fats in foodstuffs     |       Increased sound absorption for nonwoven materials     |       Prevention of flavour volatile loss during cooking     |       Do you use Yet2, Ninesigma or Innocentive? Why?     |       Post your tech requests on IP Net for free     |

Overview       Browse IP offers       Browse tech requests       Advanced Search       Testimonials       FAQs       Encouraging open innovation       What makes this different?       Our Sponsors & Partners

Email this IP record To email address From email address Email subject Email message IP Net technology offering #IP0000353 Title Method for creating Induced Pluripotent Stem Cells What the technology is A safer non-viral plasmid vector for generating induced pluripotent stem cells (iPS). What it does This non-viral reprogramming technology enables complete elimination of exogenous reprogramming factors and provides a safer method for producing iPS cells for drug screening, regenerative medicine and establishment of disease models. Possible applications Establishment of iPS cells as research tools to study the processes of pluripotency; Production of research kits cells; Production of unlimited supplies of reliable human pluripotent cells for in vitro drug screening Perceived UNIQUE ADVANTAGES Simple and quick – all four reprogramming factors are transfected at the same time; Unlimited supplies of standardised human iPS cells can be produced for regenerative medicine and drug screening Further Information such as stage of development A PCT Patent application has been filed. The University of Edinburgh would like to hear from companies wishing to license this technology to develop iPS tools and reagents and/or collaborate in its further development. Link to further info Organisation marketing this The University of Edinburgh Country Location United Kingdom Reference number 2048 Contact name Alex Proudfoot Contact phone number Search the IP Net database   Advanced search View other IP Net Technologies that may have synergy with this Send a message to this IP provider Message Your name Your organisation Your email address